Cspc Pharmaceuti Stock Price, News & Analysis
Company Description
Cspc Pharmaceuti (OTC Link: CSPCY) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $14.8B.
CSPCY stock has gained 43.9% over the past year. Shares last traded at $4.38.
This page provides a comprehensive overview of CSPCY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cspc Pharmaceuti (CSPCY) stock last traded at $4.38, up 3.65% from the previous close. Over the past 12 months, the stock has gained 43.9%. At a market capitalization of $14.8B, CSPCY is classified as a large-cap stock with approximately 2.9B shares outstanding.
Latest News
Cspc Pharmaceuti has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all CSPCY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cspc Pharmaceuti (CSPCY) currently stands at 1.4 thousand shares, down 14.8% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 59.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cspc Pharmaceuti (CSPCY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CSPCY Company Profile & Sector Positioning
Cspc Pharmaceuti (CSPCY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CSPCY often look at related companies in the same sector, including Astellas Pharma (ALPMY), Otsuka Holdings (OTSKY), Otsuka Holdings (OTSKF), Bayer Aktien (BAYRY), and Bayer A G (BAYZF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CSPCY's relative position within its industry.